NCT00531895View on ClinicalTrials.gov

An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

March 31, 2007

Conditions
Major DepressionChronic Primary Headache
Interventions
DRUG

duloxetine

duloxetine 60 mg/d

Trial Locations (1)

30000-000

Hospital SOCOR, Belo Horizonte

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Kraepelin Psiquiatria Clinica

OTHER

NCT00531895 - An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache | Biotech Hunter | Biotech Hunter